Elevated abundance, size, and MicroRNA content of plasma extracellular vesicles in viremic HIV-1+ patients: Correlations with known markers of disease progression

Journal of Acquired Immune Deficiency Syndromes

Volumn 70, Issue 3, 2015, Pages 219-227

  Hubert, Audrey ^a   Subra, Caroline ^a   Jenabian, Mohammad Ali ^b   Labrecque, Pierre François Tremblay ^a   Tremblay, Cécile ^c   Laffont, Benoit ^a   Provost, Patrick ^a   Routy, Jean Pierre ^d   Gilbert, Caroline ^a  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^d MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Biomarker; CD4 CD8 T cell ratio; DAP 3; exosomes; HIV 1; Inflammation; microRNA; Microvesicles; miR 155; miR 223

Indexed keywords

ACETYLCHOLINESTERASE; ANTIRETROVIRUS AGENT; BIOLOGICAL MARKER; CD4 ANTIGEN; CD8 ANTIGEN; MICRORNA; MICRORNA 155; MICRORNA 223; MICRORNA 92; PROTEIN; UNCLASSIFIED DRUG; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ARTICLE; CD4 CD8 RATIO; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; EXOSOME; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNE STATUS; IMMUNOSTIMULATION; INFLAMMATION; LIGHT SCATTERING; MALE; NEUTROPHIL COUNT; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; THROMBOCYTE COUNT; VIREMIA; VIRUS PATHOGENESIS; WESTERN BLOTTING; BLOOD; CD4+ T LYMPHOCYTE; CHEMISTRY; HIV INFECTIONS; ISOLATION AND PURIFICATION; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY;

ADULT; ANTI-HIV AGENTS; BIOMARKERS; CD4-CD8 RATIO; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; EXOSOMES; EXTRACELLULAR VESICLES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MICRORNAS; MIDDLE AGED; VIREMIA;

EID: 84944456832     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000756     Document Type: Article

References (43)

1. Deeks SG, Tracy R, Douek DC. Systemic effects of inflammation on health during chronic HIV infection. Immunity. 2013;39:633-645.
2. Pereyra F, Lo J, Triant VA, et al. Increased coronary atherosclerosis and immune activation in HIV-1 elite controllers. AIDS. 2012;26:2409-2412.
3. Klatt NR, Chomont N, Douek DC, et al. Immune activation and HIV persistence: implications for curative approaches to HIV infection. Immunol Rev. 2013;254:326-342.
4. Brenchley JM, Schacker TW, Ruff LE, et al. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med. 2004;200:749-759.
5. Gougeon ML, Laurent-Crawford AG, Hovanessian AG, et al. Direct and indirect mechanisms mediating apoptosis during HIV infection: contribution to in vivo CD4 T cell depletion. Semin Immunol. 1993;5:187-194.
6. Haase AT. Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in lymphatic tissues. Annu Rev Immunol. 1999;17:625-656.
7. Doitsh G, Cavrois M, Lassen KG, et al. Abortive HIV infection mediates CD4 T cell depletion and inflammation in human lymphoid tissue. Cell. 2010;143:789-801.
8. Doitsh G, Galloway NL, Geng X, et al. Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection. Nature. 2014;505:509-514.
9. Gasper-Smith N, Crossman DM, Whitesides JF, et al. Induction of plasma (TRAIL), TNFR-2, fas ligand, and plasma microparticles after human immunodeficiency virus type 1 (HIV-1) transmission: implications for HIV-1 vaccine design. J Virol. 2008;82:7700-7710.
10. Buzas EI, Gyorgy B, Nagy G, et al. Emerging role of extracellular vesicles in inflammatory diseases. Nat Rev Rheumatol. 2014;10:356-364.
11. Baur AS. HIV-Nef and AIDS pathogenesis: are we barking up the wrong tree? Trends Microbiol. 2011;19:435-440.
12. Gyorgy B, Szabo TG, Pasztoi M, et al. Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci. 2011;68:2667-2688.
13. Robbins PD, Morelli AE. Regulation of immune responses by extracellular vesicles. Nat Rev Immunol. 2014;14:195-208.
14. Thery C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol. 2009;9:581-593.
15. Lagos-Quintana M, Rauhut R, Lendeckel W, et al. Identification of novel genes coding for small expressed RNAs. Science. 2001;294:853-858.
16. O'Connell RM, Chaudhuri AA, Rao DS, et al. MicroRNAs enriched in hematopoietic stem cells differentially regulate long-term hematopoietic output. Proc Natl Acad Sci USA. 2010;107:14235-14240.
17. O'Connell RM, Rao DS, Chaudhuri AA, et al. Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol. 2010;10:111-122.
18. Seddiki N, Brezar V, Ruffin N, et al. Role of miR-155 in the regulation of lymphocyte immune function and disease. Immunology. 2014;142:32-38.
19. Laffont B, Corduan A, Ple H, et al. Activated platelets can deliver mRNA regulatory Ago2∗microRNA complexes to endothelial cells via micro-particles. Blood. 2013;122:253-261.
20. Taibi F, Metzinger-Le Meuth V, Massy ZA, et al. miR-223: an inflammatory oncomiR enters the cardiovascular field. Biochim Biophys Acta. 2014;1842:1001-1009.
21. Li M, Guan X, Sun Y, et al. miR-92a family and their target genes in tumorigenesis and metastasis. Exp Cell Res. 2014;323:1-6.
22. Corrado C, Raimondo S, Chiesi A, et al. Exosomes as intercellular signaling organelles involved in health and disease: basic science and clinical applications. Int J Mol Sci. 2013;14:5338-5366.
23. Pegtel DM, Cosmopoulos K, Thorley-Lawson DA, et al. Functional delivery of viral miRNAs via exosomes. Proc Natl Acad Sci USA. 2010; 107:6328-6333.
24. Ramakrishnaiah V, Thumann C, Fofana I, et al. Exosome-mediated transmission of hepatitis C virus between human hepatoma Huh7.5 cells. Proc Natl Acad Sci USA. 2013;110:13109-13113.
25. Subra C, Simard S, Mercier S, et al. Dendritic cells Pulsed with HIV-1 release exosomes that promote apoptosis in CD4+ T lymphocytes. J Clin Cell Immunol. 2011. (S7:001. doi:10.4172/2155-9899.S7).
26. Lenassi M, Cagney G, Liao M, et al. HIV Nef is secreted in exosomes and triggers apoptosis in bystander CD4+ T cells. Traffic. 2010;11: 110-122.
27. Arenaccio C, Chiozzini C, Columba-Cabezas S, et al. Exosomes from Human Immunodeficiency virus type-1 (HIV-1)-infected cells license quiescent CD4+ T lymphocytes to replicate HIV-1 through a Nef-and ADAM17-dependent mechanism. J Virol. 2014;88:11529-11539.
28. Arenaccio C, Chiozzini C, Columba-Cabezas S, et al. Cell activation and HIV-1 replication in unstimulated CD4+ T lymphocytes ingesting exo-somes from cells expressing defective HIV-1. Retrovirology. 2014;11:46.
29. Izquierdo-Useros N, Naranjo-Gomez M, Erkizia I, et al. HIV and mature dendritic cells: Trojan exosomes riding the Trojan horse? PLoS Pathog. 2010;6:e1000740.
30. Narayanan A, Iordanskiy S, Das R, et al. Exosomes derived from HIV-1-infected cells contain trans-activation response element RNA. J Biol Chem. 2013;288:20014-20033.
31. Frleta D, Ochoa CE, Kramer HB, et al. HIV-1 infection-induced apoptotic microparticles inhibit human DCs via CD44. J Clin Invest. 2012;122:4685-4697.
32. Kadiu I, Narayanasamy P, Dash PK, et al. Biochemical and biologic characterization of exosomes and microvesicles as facilitators of HIV-1 infection in macrophages. J Immunol. 2012;189:744-754.
33. Cantin R, Diou J, Belanger D, et al. Discrimination between exosomes and HIV-1: purification of both vesicles from cell-free supernatants. J Immunol Methods. 2008;338:21-30.
34. Columba Cabezas S, Federico M. Sequences within RNA coding for HIV-1 Gag p17 are efficiently targeted to exosomes. Cell Microbiol. 2013;15:412-429.
35. Gilbert C, Rollet-Labelle E, Caon AC, et al. Immunoblotting and sequential lysis protocols for the analysis of tyrosine phosphorylation-dependent signaling. J Immunol Methods. 2002;271:185-201.
36. Taylor JM, Fahey JL, Detels R, et al. CD4 percentage, CD4 number, and CD4:CD8 ratio in HIV infection: which to choose and how to use. J Acquir Immune Defic Syndr. 1989;2:114-124.
37. Boulassel MR, Chomont N, Pai NP, et al. CD4 T cell nadir independently predicts the magnitude of the HIV reservoir after prolonged suppressive antiretroviral therapy. J Clin Virol. 2012;53:29-32.
38. Bignami F, Pilotti E, Bertoncelli L, et al. Stable changes in CD4+ T lymphocyte miRNA expression after exposure to HIV-1. Blood. 2012; 119:6259-6267.
39. Vickers KC, Palmisano BT, Shoucri BM, et al. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol. 2011;13:423-433.
40. Konadu KA, Chu J, Huang MB, et al. Association of cytokines with exosomes in the plasma of HIV-1-Seropositive individuals. J Infect Dis. 2015;211:1712-1716.
41. Lind EF, Elford AR, Ohashi PS. Micro-RNA 155 is required for optimal CD8+ T cell responses to acute viral and intracellular bacterial challenges. J Immunol. 2013;190:1210-1216.
42. Kohlhaas S, Garden OA, Scudamore C, et al. Cutting edge: the Foxp3 target miR-155 contributes to the development of regulatory T cells. J Immunol. 2009;182:2578-2582.
43. Ruelas DS, Chan JK, Oh E, et al. MicroRNA-155 Reinforces HIV latency. J Biol Chem. 2015;290:13736-13748.